The removal of Tung Tung Tung Sahur, an AI-generated character, from a popular Roblox game raises some profound intellectual ...

The final reason Roblox is everywhere: it's polarizing. The stock has more than doubled in 2025 and now trades at 19 times sales -- a multiple that assumes near-flawless execution. Yet Roblox remains ...

Half of the U.S. population under the age of 16 are playing Roblox. Here's how to keep your kids safe on the platform.

Maybe you moved and didn't notify your bank or simply forgot about an old account or policy. But money companies owe individuals they can't locate winds up getting handed over to the government. We ...

Billionaires of all political stripes fund groups that push their preferred sentiments, and some of the organizations working on the "No Kings" movement have received grant money or other funds from ...

NEW YORK (WABC) -- Maybe you moved and didn't notify your bank or simply forgot about an old account or policy. But money companies owe individuals they can't locate winds up getting handed over to ...

When fall hits Seattle and months of rainy weather stretch ahead of us, it’s the perfect time to stay inside, pick up a new board game and find a group to play with to while the gray days away.

Sign up for The Morning Report with all your must-read news for the day. For eight years, David Smith constantly monitored the Navajo Community Planning Group’s ...

Women in Games, Out Making Games, and BAME in Games call for transparent age ratings rather than vague "sensitive issues" label. When you purchase through links on our site, we may earn an affiliate ...

Beysi Vazquez tends to thousands of basil, dill, mint and other herbs in a large sprawling nursery business in California’s Coachella Valley, just north of the Salton Sea. She works long shifts, in ...

Roblox Corp. is facing criticism from three advocacy groups who say the parental approval required before children can play games involving “sensitive issues” like marriage equality and pay equity in ...

Bolt Biotherapeutics has halved its workforce for the second time in two years as the oncology biotech delays a readout of its lead immunotherapy. The company had previously been expecting initial ...